Overview

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population

Status:
RECRUITING

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

Summary

To assess the effectiveness of Amisulpride to treat Post Operative Nausea and Vomiting (PONV) and to assess the effectiveness of Amisulpride to prevent PONV following bariatric surgery.

Phase:

PHASE3

Details

Lead Sponsor:

Benaroya Research Institute

Collaborator:

Virginia Mason Hospital/Medical Center